The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Authors
Keywords
-
Journal
Lancet Microbe
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-01-26
DOI
10.1016/s2666-5247(21)00237-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis
- (2021) Sameh S. M. Soliman et al. Nature Microbiology
- EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group
- (2021) Matteo Bassetti et al. CLINICAL INFECTIOUS DISEASES
- Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
- (2021) Martin Hoenigl et al. LANCET INFECTIOUS DISEASES
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Fulminant mucormycosis complicating coronavirus disease 2019 (COVID‐19)
- (2021) Mahboobeh Karimi‐Galougahi et al. International Forum of Allergy & Rhinology
- A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19
- (2021) Anubhav Kanwar et al. Journal of Fungi
- Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
- (2021) Christoph Zurl et al. Journal of Fungi
- Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report
- (2021) Amirreza Veisi et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection
- (2021) Anthony J. Carlos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of Sex Differences in Murine Diabetic Ketoacidosis and Neutropenic Models of Invasive Mucormycosis
- (2021) Teclegiorgis Gebremariam et al. Journal of Fungi
- When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
- (2021) Teny M. John et al. Journal of Fungi
- Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
- (2021) Juergen Prattes et al. INTENSIVE CARE MEDICINE
- Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature
- (2021) Akshay Khatri et al. JOURNAL DE MYCOLOGIE MEDICALE
- ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
- (2021) Shivaprakash M. Rudramurthy et al. MYCOSES
- Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
- (2021) Andre K. Johnson et al. Medical Mycology Case Reports
- Clinicians’ Challenges in Managing Patients with Invasive Fungal Diseases in Seven Asian Countries: An Asia Fungal Working Group (AFWG) Survey
- (2020) Ban Hock Tan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Mucormycosis
- (2020) Gail Reid et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis
- (2020) Hélène Guegan et al. JOURNAL OF INFECTION
- GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis
- (2020) Abdullah Alqarihi et al. mBio
- No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science
- (2020) Monica Salerno et al. Journal of Clinical Medicine
- Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19
- (2020) C. Poignon et al. CLINICAL MICROBIOLOGY AND INFECTION
- Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group
- (2020) S Rocchi et al. MEDICAL MYCOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
- (2020) Amir Arastehfar et al. Journal of Fungi
- Mucormycosis with orbital compartment syndrome in a patient with COVID-19
- (2020) Amanda Werthman-Ehrenreich AMERICAN JOURNAL OF EMERGENCY MEDICINE
- COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
- (2020) Amir Arastehfar et al. Journal of Fungi
- A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
- (2020) Daniela Pasero et al. INFECTION
- Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance
- (2020) Philipp Koehler et al. LANCET INFECTIOUS DISEASES
- Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome
- (2020) Zesemayat K. Mekonnen et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC
- (2020) Barbara D Alexander et al. CLINICAL INFECTIOUS DISEASES
- An aero mycological analysis of Mucormycetes in indoor and outdoor environments of northern India
- (2019) Hariprasath Prakash et al. MEDICAL MYCOLOGY
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
- (2019) J Peter Donnelly et al. CLINICAL INFECTIOUS DISEASES
- A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India
- (2019) A. Patel et al. CLINICAL MICROBIOLOGY AND INFECTION
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
- (2019) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
- (2018) John R. Perfect et al. MYCOSES
- Rare Mold Infections Caused by Mucorales, Lomentospora Prolificans and Fusarium , San Diego: The Role of Antifungal Combination Therapy
- (2018) Jeffrey D. Jenks et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mucorales spores induce a proinflammatory cytokine response in human mononuclear phagocytes and harbor no rodlet hydrophobins
- (2017) Sebastian Wurster et al. Virulence
- RNAi-Based Functional Genomics Identifies New Virulence Determinants in Mucormycosis
- (2017) Trung Anh Trieu et al. PLoS Pathogens
- Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates
- (2017) Jesús Guinea et al. PLoS One
- Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF)
- (2016) L. Millon et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients
- (2011) L. Potenza et al. BLOOD
- The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts
- (2011) S. P. Georgiadou et al. CLINICAL INFECTIOUS DISEASES
- In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes
- (2009) E. Dannaoui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AMBIZYGO : étude de phase II de l’efficacité d’une posologie initiale élevée d’amphotéricine B liposomale (AmBisome®) [10 mg/kg/j] dans le traitement des zygomycoses
- (2008) F. Lanternier et al. MEDECINE ET MALADIES INFECTIEUSES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now